Ginsenoside Rg4 [CAS 126223-28-7]

Ginsenoside Rg4 is an orally active protopanaxatriol type ginsenoside. Ginsenoside Rg4 can activate PI3K, AKT and GSK-3β signaling. Ginsenoside Rg4 can inhibit ROS and inflammatory cytokine levels. Ginsenoside Rg4 can be used for the researches of inflammation, infection and metabolic disease, such as sepsis and lung inflammation[1][2][3].

[126223-28-7]

C42H70O12

767

C[C@]12[C@@]3(C)[C@@]([H])([C@H](CC3)/C(C)=C\C/C=C(C)\C)[C@@H](C[C@@]1([C@]4(C)[C@@]([H])([C@H](C2)O[C@]5([C@H](O[C@]6([C@H](O)[C@H](O)[C@H]([C@@H](O6)C)O)[H])[C@@H](O)[C@@H]([C@H](O5)CO)O)[H])C([C@H](CC4)O)(C)C)[H])O

Akt; GSK-3; Interleukin Related; PI3K; Reactive Oxygen Species (ROS) ; TNF Receptor

GSK-3β; IL-1

99.94

DMSO : 5 mg/mL (ultrasonic)

-80°C, protect from light

Dry Ice